Abstract Title:

A new phenanthrene derivative and two diarylheptanoids from the roots of Brassica rapa ssp. campestris inhibit the growth of cancer cell lines and LDL-oxidation.

Abstract Source:

Arch Pharm Res. 2013 Apr ;36(4):423-9. Epub 2013 Feb 24. PMID: 23435947

Abstract Author(s):

Qian Wu, Jin-Gyeong Cho, Ki-Hyun Yoo, Tae-Sook Jeong, Ji-Hae Park, Su-Yeon Kim, Ji-Hyun Kang, In-Sik Chung, Myung-Sook Choi, Kyung-Tae Lee, Hae-Gon Chung, Myun-Ho Bang, Nam-In Baek

Article Affiliation:

Qian Wu

Abstract:

Brassica rapa ssp. campestris (Brassicaceae) is a conical, deep purple, edible root vegetable commonly known as a turnip. We initiated phytochemical and pharmacological studies to search for biological active compounds from the roots of B. rapa ssp. campestris. We isolated a novel phenanthrene derivative, 6-methoxy-1-[10-methoxy-7-(3-methylbut-2-enyl)phenanthren-3-yl]undecane-2,4-dione, named brassicaphenanthrene A (3) along with two known diarylheptanoid compounds, 6-paradol (1) and trans-6-shogaol (2), through the repeated silica gel (SiO2), octadecyl silica gel, and Sephadex LH-20 column chromatography. The chemical structures of the compounds were determined by spectroscopic data analyses including nuclear magnetic resonance, mass spectrometry, ultraviolet spectroscopy, and infra-red spectroscopy. All compounds exhibited high inhibitory activity against the growth of human cancer lines, HCT-116, MCF-7, and HeLa, with IC50 values ranging from 15.0 to 35.0μM and against LDL-oxidation with IC50 values ranging from 2.9 to 7.1 μM.

Print Options


This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.